Additionally, the use of small molecules that inhibit TFRC function has been explored as a potential strategy to disrupt iron homeostasis in cancer cells, thereby inducing ferroptosis, a form of regulated cell death characterized by iron-dependent oxidative stress (36). Here, TFRC is linked to cancer.